Related Experiment Videos
Secondary (non-GpC) binding sites for actinomycin on DNA
1Department of Physiology and Pharmacology, University of Southampton, UK.
Biochimica Et Biophysica Acta
|July 15, 1992
Summary
Actinomycin D, an antibiotic, binds to DNA. Researchers found it also binds to GG/CC sequences, not just the usual GC sites, especially when DNA has specific flanking regions.
Area of Science:
- Molecular Biology
- Biochemistry
- Drug Discovery
Background:
- Actinomycin D is a known DNA-binding antibiotic.
- Its canonical binding site is the GpC dinucleotide step.
Purpose of the Study:
- To investigate Actinomycin D's binding to non-canonical DNA sequences.
- To explore sequence-specific DNA-drug interactions.
Main Methods:
- Utilized synthetic DNA fragments.
- Employed DNase I footprinting experiments to map binding sites.
Main Results:
- Actinomycin D binds effectively to GG/CC sequences.
- Binding to GC and GG/CC sites is enhanced by (GT)n.(AC)n flanking regions.
- Specific, cooperative binding to GT and AC sequences was observed.
Conclusions:
- Actinomycin D exhibits broader DNA sequence binding than previously known.
- Non-canonical binding sites and flanking sequences influence drug interaction.
- Findings may inform development of novel DNA-targeting agents.